Advair HFA (salmeterol/fluticasone propionate) inhalation aerosol
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Advair HFA (salmeterol/fluticasone propionate) inhalation aerosol, covering 2009-08-04 to 2009-08-04. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Assessment Of GW815SF Salmeterol/Fluticasone Propionate(HFA MDI) In Pediatric Patients With Bronchial Asthma -A Long Term (24-week) Study- [Phase 3]